Balyasny Asset Management »

Upstream Bio shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 73k 18.81
2024-12-31 $5.0M 301k 16.44

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Decheng Capital
BlackRock
Enavate Sciences GP
Vanguard Group
Bain Capital Life Sciences Investors
TCG Crossover Management
Altshuler Shaham
Omega Fund Management
VR Adviser
Wellington Management Company
State Street Corporation
Samsara BioCapital
Marshall Wace

View all funds holding Upstream Bio